Document is current
Any future updates will be listed below
-
Authors
Peltonen, Essi J. https://orcid.org/0000-0002-5782-3089
Veijola, Riitta
Ilonen, Jorma
Knip, Mikael
Niinikoski, Harri
Toppari, Jorma
Virtanen, Helena E.
Virtanen, Suvi M.
Peltonen, Jaakko
Nevalainen, Jaakko
-
Funding
Funding for this research was provided by:
Academy of Finland (63672)
Academy of Finland (68292)
Academy of Finland (79685)
Academy of Finland (79686)
Academy of Finland (80846)
Academy of Finland (114666)
Academy of Finland (126813)
Academy of Finland (129492)
Academy of Finland (139391)
Academy of Finland (201988)
Academy of Finland (210632)
Academy of Finland (276475)
Academy of Finland (307996)
Academy of Finland (308065)
Academy of Finland (308066)
Academy of Finland (Center of Excellence in Molecular Systems Immunology)
Academy of Finland (Physiology Research 2012-2017)
Academy of Finland (Decision No. 250114)
European Foundation for the Study of Diabetes
Diabetesliitto
Diabetestutkimussäätiö
Juho Vainion Säätiö
JDRF International (4-1998-274)
JDRF International (4-1999-731)
JDRF International (4-2001-435)
JDRF International (1-SRA-2016-342-M-R)
JDRF International (1-SRA-2019-732-M-B)
JDRF International (3-SRA-2020-955-S-B)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9E082)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9F089)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9G087)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9H092)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9J147)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9K149)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9L042)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9L117)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9M114)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9N086)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9P057)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9R055)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9S074)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9U065)
Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9V072)
Oulun Yliopistollinen Sairaala
Turun Yliopistollinen Keskussairaala (state research funding VTR))
European Comission (BMH4-CT98-3314)
Novo Nordisk Fonden
Special Research Funds for University Hospitals in Finland
Sigrid Juséliuksen Säätiö
Alfred Kordelinin Säätiö (200356)
Tampere University including Tampere University Hospital, Tampere University of Applied Sciences
- License Information
-
More Information
Article History
Received: 21 August 2022
Accepted: 31 March 2023
First Online: 20 April 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The study adheres to the Declaration of Helsinki, and the ethics committee of Northern Ostrobothnia Hospital District has approved the study protocol. Data were pseudonymized before the corresponding author accessed them for the analyses.
: Parents gave their written informed consent for genetic testing of their newborn infant and for participation in the follow-up.
